Bevicra 400mg Bevacizumab Injection

Bevicra 400mg Bevacizumab Injection is a prescription anti-cancer medication used in the treatment of various cancers, including colorectal cancer, non-small cell lung cancer, kidney cancer, ovarian cancer, and cervical cancer. It contains Bevacizumab, a targeted monoclonal antibody that works by blocking vascular endothelial growth factor (VEGF), a protein that promotes the formation of blood vessels supplying tumors. By restricting the tumor’s blood supply, Bevicra 400mg Bevacizumab Injection helps slow cancer growth and reduce the spread of cancer cells. Administered as an intravenous infusion under the supervision of an oncology specialist, it is often used in combination with chemotherapy or other cancer therapies. Regular monitoring during treatment is essential to evaluate effectiveness and manage potential side effects. Patients should use Bevicra 400mg Injection only as directed by their healthcare provider.